Innovation Endeavors III LP's Form 4/A amendment
AmendedVicarious Surgical Inc. (RBOT) · filed Jun 3, 2022
- Accession no.
- 0001213900-22-031138
- Filed
- Jun 3, 2022, 4:13 PM ET
- Trade date
- Sep 17, 2021
- Filing delay
- 259 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 23, 2021
This filing lists 2 non-derivative transactions. Open-market purchases total $3.33M. It was filed 259 days after the trade.
This amendment replaces 0001213900-21-049655 (filed Sep 23, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Innovation Endeavors III LPCIK 0001720215 | 10% Owner |
| Berman DrorCIK 0001883780 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Class A Common Stock | AGrant or awardAcquired | +13,436,810 | –F1 | – | 13,436,810 | Direct | |
| Sep 17, 2021 | Class A Common Stock | PPurchaseAcquired | +333,333 | $10.00 | +$3,333,330 | 13,770,143 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
In connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among D8 Holdings Corp. ("D8"), Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of D8 ("Merger Sub"), and Vicarious Surgical Inc., a Delaware corporation ("Vicarious"), pursuant to which Merger Sub merged with and into Vicarious, with Vicarious surviving as a wholly-owned subsidiary of D8 (which changed its name to "Vicarious Surgical Inc.", the "Issuer"), these shares were received in exchange for 3,313,025 Series A1 Preferred Stock, 456,520 Series A2 Preferred Stock and 304,302 Series A3 Preferred Stock of Vicarious (such transactions, the "Closing").
Referenced by the price of 1 transaction in Table I.
- F2
Dror Berman is a managing partner at Innovation Endeavors III LP and may be deemed to share voting and dispositive power over the shares held by Innovation Endeavors III LP. Such persons and entities disclaim beneficial ownership of shares held by Innovation Endeavors III LP, except to the extent of any pecuniary interest therein.
- F3
Innovation Endeavors III LP purchased 333,333 shares of Class A common stock from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the Closing.
Remarks
This Form 4 amendment is being filed to include the 333,333 shares of Class A common stock purchased by Innovation Endeavors III LP from the Issuer, at a price of $10.00 per share, in a private placement immediately prior to the Closing. This Form 4 amendment is intended to replace, in its entirety, the Form 4 filed on September 23, 2021.